Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14227245
[patent_doc_number] => 20190125795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
[patent_app_type] => utility
[patent_app_number] => 16/071457
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071457 | Compositions and methods for immune cell modulation in adoptive immunotherapies | Jan 19, 2017 | Issued |
Array
(
[id] => 13955559
[patent_doc_number] => 20190054123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => CELL SHEET COMPOSITION INCLUDING MESENCHYMAL STEM CELLS, AND METHOD FOR HEALING LUMINAL ORGAN USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/072109
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072109 | CELL SHEET COMPOSITION INCLUDING MESENCHYMAL STEM CELLS, AND METHOD FOR HEALING LUMINAL ORGAN USING SAME | Jan 16, 2017 | Abandoned |
Array
(
[id] => 11689663
[patent_doc_number] => 20170165378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'COMPOSITION FOR TREATING CANCEROUS CELLS AND A METHOD THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 15/407912
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 14054
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15407912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/407912 | Composition for treating cancerous cells and a method therefor | Jan 16, 2017 | Issued |
Array
(
[id] => 11602529
[patent_doc_number] => 20170119829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'METHOD FOR INDUCING PRODUCTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR'
[patent_app_type] => utility
[patent_app_number] => 15/404076
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5887
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404076
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/404076 | METHOD FOR INDUCING PRODUCTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR | Jan 10, 2017 | Abandoned |
Array
(
[id] => 14435575
[patent_doc_number] => 20190175659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHOD FOR INDUCING TRANSDIFFERENTIATION OF FIBROBLASTS INTO CHONDROCYTES
[patent_app_type] => utility
[patent_app_number] => 16/071117
[patent_app_country] => US
[patent_app_date] => 2017-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071117
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071117 | Method for inducing transdifferentiation of fibroblasts into chondrocytes | Jan 1, 2017 | Issued |
Array
(
[id] => 13565879
[patent_doc_number] => 20180334487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => COMPOSITIONS FOR USE IN RECOVERING OR AMELIORATING DETERIORATION OF PHYSIOLOGICAL FUNCTIONS DUE TO AGING
[patent_app_type] => utility
[patent_app_number] => 15/777019
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777019
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777019 | Compositions for use in recovering or ameliorating deterioration of physiological functions due to aging | Dec 26, 2016 | Issued |
Array
(
[id] => 17178355
[patent_doc_number] => 11155589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Generation of antigen-specific TCRs
[patent_app_type] => utility
[patent_app_number] => 16/065024
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19303
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065024 | Generation of antigen-specific TCRs | Dec 21, 2016 | Issued |
Array
(
[id] => 13827173
[patent_doc_number] => 20190017071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => METHOD FOR THE OPTOINJECTION OF EXOGENOUS MATERIAL INTO A BIOLOGICAL CELL
[patent_app_type] => utility
[patent_app_number] => 16/067217
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 359
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067217 | Method for the optoinjection of exogenous material into a biological cell | Dec 19, 2016 | Issued |
Array
(
[id] => 11554212
[patent_doc_number] => 20170100458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'USE OF CPNE7 FOR DIFFERENTIATING NON-DENTAL MESENCHYMAL STEM CELLS INTO ODONTOBLASTS, REGENERATING DENTAL PULP AND TREATING DENTIN HYPERSENSITIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/381984
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 13168
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15381984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/381984 | Use of CPNE7 for differentiating non-dental mesenchymal stem cells into odontoblasts, regenerating dental pulp and treating dentin hypersensitivity | Dec 15, 2016 | Issued |
Array
(
[id] => 11954765
[patent_doc_number] => 20170258915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Delivery and Formulation of Engineered Nucleic Acids'
[patent_app_type] => utility
[patent_app_number] => 15/379284
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 48175
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15379284
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/379284 | Delivery and formulation of engineered nucleic acids | Dec 13, 2016 | Issued |
Array
(
[id] => 12445530
[patent_doc_number] => 09981023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Compositions and methods for inducing immune tolerance
[patent_app_type] => utility
[patent_app_number] => 15/370313
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 8800
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15370313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/370313 | Compositions and methods for inducing immune tolerance | Dec 5, 2016 | Issued |
Array
(
[id] => 17222004
[patent_doc_number] => 11174495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Reporter system for detecting and targeting activated cells
[patent_app_type] => utility
[patent_app_number] => 15/780852
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 13816
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780852 | Reporter system for detecting and targeting activated cells | Dec 4, 2016 | Issued |
Array
(
[id] => 13622847
[patent_doc_number] => 20180362975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY
[patent_app_type] => utility
[patent_app_number] => 15/780751
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 205730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -89
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780751 | Compositions and methods for immunooncology | Dec 1, 2016 | Issued |
Array
(
[id] => 12766393
[patent_doc_number] => 20180147299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => GENE THERAPY VECTOR SYSTEM AND PRODRUG GENES
[patent_app_type] => utility
[patent_app_number] => 15/365117
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/365117 | Gene therapy vector system and prodrug genes | Nov 29, 2016 | Issued |
Array
(
[id] => 17665377
[patent_doc_number] => 11359058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Processes and systems for preparing cellular or viral membranes and nanoparticles
[patent_app_type] => utility
[patent_app_number] => 15/777208
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 18114
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777208
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777208 | Processes and systems for preparing cellular or viral membranes and nanoparticles | Nov 17, 2016 | Issued |
Array
(
[id] => 16681914
[patent_doc_number] => 10941381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Method of manufacturing dual-specific T-cells for use in cancer immunotherapy
[patent_app_type] => utility
[patent_app_number] => 15/777399
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 9
[patent_no_of_words] => 13188
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/777399 | Method of manufacturing dual-specific T-cells for use in cancer immunotherapy | Nov 17, 2016 | Issued |
Array
(
[id] => 14963691
[patent_doc_number] => 20190309324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among others
[patent_app_type] => utility
[patent_app_number] => 15/773723
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15773723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/773723 | AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among others | Nov 3, 2016 | Issued |
Array
(
[id] => 16761080
[patent_doc_number] => 20210106661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 15/770648
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770648
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770648 | METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING PM20D1 AND N-LIPIDATED AMINO ACIDS | Oct 27, 2016 | Pending |
Array
(
[id] => 13093381
[patent_doc_number] => 10066023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Compositions and methods for tumor transduction
[patent_app_type] => utility
[patent_app_number] => 15/317877
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 12922
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317877
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317877 | Compositions and methods for tumor transduction | Oct 27, 2016 | Issued |
Array
(
[id] => 14665531
[patent_doc_number] => 10370656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Nucleic acid functionalized nanoparticles for therapeutic applications
[patent_app_type] => utility
[patent_app_number] => 15/296387
[patent_app_country] => US
[patent_app_date] => 2016-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18036
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15296387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/296387 | Nucleic acid functionalized nanoparticles for therapeutic applications | Oct 17, 2016 | Issued |